Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

26 January 2021

Uitzending van 26 januari 2021

Marijn Verhoef, Company Engagement Manager for the Access to Medicine Foundation, joins Dutch radio news station NPO to discuss the 2021 Access to Medicine Index.

Direct links

Listen to the interview

Speaking in Dutch, Marijn discusses the 2021 Access to Medicine Index. In the interview, Marijn touches on the following points:

  • The surge of new R&D projects in the wake of COVID-19 while research into other pandemic risks lag

  • The pharmaceutical industry's progress on access to medicine, including improving access to essential products 

  • Equitable access to COVID-19 vaccines as a key element in controlling the pandemic and the responsibility of pharmaceutical companies to distribute vaccines fairly throughout different parts of the world.

The interview starts at around 28 minutes and is conducted in Dutch. The full interview can be found here. 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved